Translocation (X;12)(p11;p13) as a sole abnormality in biphenotypic acute leukemia

Cancer Genetics and Cytogenetics

Volumn 173, Issue 2, 2007, Pages 159-163

  Manola, Kalliopi N ^a   Georgakakos, Vasileios N ^a   Marinakis, Theodore ^b   Stavropoulou, Chryssa ^a   Paterakis, George ^b   Anagnostopoulos, Nikolaos I ^b   Pantelias, Gabriel E ^a   Sambani, Constantina ^a  

^a INSTITUTE OF NANOSCIENCE AND NANOTECHNOLOGY   (Greece)

^b G GENNIMATAS GENERAL HOSPITAL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

BCR ABL PROTEIN; CYTARABINE; IDARUBICIN; MIXED LINEAGE LEUKEMIA PROTEIN; TRANSCRIPTION FACTOR ETV6;

ACUTE LEUKEMIA; ADULT; ARTICLE; CASE REPORT; CHROMOSOME 12P; DRUG MEGADOSE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; PRIORITY JOURNAL; X CHROMOSOME;

ACUTE DISEASE; CHROMOSOME BANDING; CHROMOSOME PAINTING; CHROMOSOMES, HUMAN, PAIR 12; CHROMOSOMES, HUMAN, X; FEMALE; HUMANS; KARYOTYPING; LEUKEMIA; LYMPHOCYTES; MIDDLE AGED; MYELOID CELLS; TRANSLOCATION, GENETIC;

EID: 33847131878     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2006.10.012     Document Type: Article

References (24)

1. Matutes E., Morilla R., Farahat N., Carbonell F., Swansbury J., Dyer M., and Catovsky D. Definition of acute biphenotypic leukemia. Haematologica 82 (1997) 64-66
2. Owaidah T.M., Al Beihany A., Iqbal M.A., Elkum N., and Roberts G.T. Cytogenetics, molecular and ultrastructural characteristics of biphenotypic acute leukemia identified by the EGIL scoring system. Leukemia 20 (2006) 620-625
3. Bene M.C., Castoldi G., Knapp W., Ludwig W.D., Matutes E., Orfao A., and Van't Veer M.B. European Group for the Immunological Classification of Acute Leukemia (EGIL). Proposals for the immunological classification of acute leukemias. Leukemia 9 (1995) 1783-1786
4. Legrand O., Perrot J.Y., Simonin G., Baudard M., Cadiou M., Blanc C., Ramond S., Viguié F., Marie J.P., and Zittoun R. Adult biphenotypic acute leukemia: an entity with poor prognosis which is related to unfavourable cytogenetics and P-glycoprotein over-expression. Br J Haematol 100 (1998) 147-155
5. Killick S., Matutes E., Powles R.L., Hamblin M., Swansbury J., Zomas A., Atra A., and Catovsky D. Outcome of biphenotypic leukemia. Haematologica 84 (1999) 699-706
6. Frater J.L., Yaseen N.R., Peterson L.C., Tallman M.S., and Goolsby C.L. Biphenotypic acute leukemia with coexpression of CD79a and markers of myeloid lineage. Arch Pathol Lab Med 127 (2003) 356-359
7. Kozlov I., Beason K., Yu C., and Hughson M. CD79a expression in acute myeloid leukemia t(8;21) and the importance of cytogenetics in the diagnosis of leukemias with immunophenotypic ambiguity. Cancer Genet Cytogenet 163 (2005) 62-67
8. Scolnik M.P., Aranguren P.N., Cuello M.T., Palacios M.F., Sanjurjo J., Giunta M., Bracco M.M.E., and Acevedo S. Biphenotypic acute leukemia with t(15;17). Leuk Lymphoma 46 (2005) 607-610
9. Hanson C.A., Abaza M., Sheldon S., Ross C.W., Schnitzer B., and Stoolman L.M. Acute biphenotypic leukemia: immunophenotypic and cytogenetic analysis. Br J Haematol 84 (1993) 49-60
10. Michaux L., Wlodarska I., Mecucci C., Hernandez J.M., Van Orshoven V., Michaux J.L., and Van den Berghe H. Characterization by chromosome painting of balanced and unbalanced X chromosome translocations in myelodysplastic syndromes. Cancer Genet Cytogenet 82 (1995) 17-22
11. Sharp A.J., Spotswood H.T., Robinson D.O., Turner B.M., and Jacobs P.A. Molecular and cytogenetic analysis of the spreading of X inactivation in X;autosome translocations. Hum Mol Genet 11 (2002) 3145-3156
12. ISCN 2005: an international system for human cytogenetic nomenclature (2005). In: Shaffer L.G., and Tommerup N. (Eds) (2005), S. Karger, Basel
13. Inokuchi K., Shinohara T., Futaki M., Hanawa H., Tanosaki S., Yamaguchi H., Nomura T., and Dan K. Establishment of a cell line with variant BCR/ABL breakpoint expressing P180BCR/ABL from late-appearing Philadelphia-positive acute biphenotypic leukemia. Genes Chromosomes Cancer 23 (1998) 227-238
14. Wlodarska I., Veyt E., De Paepe P., Vandenberghe P., Nooijen P., Theate I., Michaux L., Sagaert X., Marynen P., Hagemeijer A., and De Wolf-Peeters C. FOXP1, a gene highly expressed in a subset of diffuse large B-cell lymphoma, is recurrently targeted by genomic aberrations. Leukemia 19 (2005) 1299-1305
15. Wlodarska I., La Starza R., Baens M., Dierlamm J., Uyttebroeck A., Selleslag D., Francine A., Selleslag D., Francine A., Mecucci C., Hagemeijer A., Van den Berghe H., and Marynen P. Fluorescence in situ hybridization characterization of new translocations involving TEL (ETV6) in a wide spectrum of hematologic malignancies. Blood 91 (1998) 1399-1406
16. Bohlander S.K. ETV6: a versatile player in leukemogenesis. Semin Cancer Biol 15 (2005) 162-174
17. Odero M.D., Carlson K., Calasanz M.J., Lahortiga I., Chinwalla V., and Rowley J.D. Identification of new translocations involving ETV6 in hematologic malignancies by fluorescence in situ hybridization and spectral karyotyping. Genes Chromosomes Cancer 31 (2001) 134-142
18. Sato Y., Kobayashi H., Suto Y., Olney H.J., Davis E.M., Super H.G., Espinosa III R., Le Beau M.M., and Rowley J.D. Chromosomal instability in chromosome band 12p13: multiple breaks leading to complex rearrangements including cytogenetically undetectable sub-clones. Leukemia 15 (2001) 1193-1202
19. Wang L.C., Swat W., Fujiwara Y., Davidson L., Visvader J., Kuo F., Alt F.W., Gilliland D.G., Golub T.R., and Orkin S.H. The TEL/ETV6 gene is required specifically for hematopoiesis in the bone marrow. Genes Dev 12 (1998) 2392-2402
20. La Starza R., Stella M., Testoni N., Di Bona E., Ciolli S., Marynen P., Martelli M.F., Mandelli F., and Mecucci C. Characterization of 12p molecular events outside ETV6 in complex karyotypes of acute myeloid malignancies. Br J Haematol 107 (1999) 340-346
21. Mrózek K., Heinonen K., and Bloomfield C.D. Clinical importance of cytogenetics in acute myeloid leukemia. Best Pract Res Clin Haematol 14 (2001) 19-47
22. Mrózek K., Heerema N.A., and Bloomfield C.D. Cytogenetics in acute leukemia. Blood Rev 18 (2004) 115-136
23. Crispino J.D. GATA1 in normal and malignant hematopoiesis. Semin Cell Dev Biol 16 (2005) 137-147
24. Merrell K., Wells S., Henderson A., Gorman J., Alt F., Stall A., and Calame K. The absence of the transcription activator TFE3 impairs activation of B cells in vivo. Mol Cell Biol 17 (1997) 3335-3344